In March of 2018, Advance Access & Delivery (AA&D) and the Lilly MDR-TB Partnership launched the first of its kind, web-based platform, the TB Drug Access Atlas. This tool highlights over 40 global projects addressing challenges related to the supply and access of quality-assured, second-line drugs for MDR-TB. This interactive platform gives users a first hand look at the burden of MDR-TB at the global and country levels and showcases projects that are working to address one or more of the following seven market indicators: affordability, delivery challenges, forecasting, market incentives, procurement, regimen complexity and regulatory complexity.
One of the intended outcomes of this tool is provide a snapshot of where opportunities exists to leverage resources in a direction that will improve access to medicines for those most in need.
Projects captured on the TB Drug Access Atlas represent activities ongoing or planned between 2014-2020. The database is organized by market indicator and geography and will be updated at regular intervals throughout the year. Please send any questions or comments to email@example.com.